Rapid Diagnostics

Selected news for the healthcare topic - Rapid Diagnostics, collected since 10/2017. This healthcare topic shares news with COVID-19, Infectious Disease, Abbott Laboratories, Public Health and dozens of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
10/8/2021 COVID-19 Update for South Sudan - 7 October 2021 reliefweb.int COVID-19 Update for South Sudan - 7 October 2021AttachmentsCOVID-19 CasesSouth Sudan still on alert for resurgence of COVID-19 despite decrease in confirmed cases in past 2 weeksDelay in reported cases from antigen rapid diagnostics tests4% of COVID-19 Strategic Preparedness and Response Plan (SPRP) budget available for basic COVID-19 response interventions until May 2022 ‚Üí unable to fill urgent gaps ‚Üí WHO ...
10/7/2021 Global Immunoassay Markets Report 2021-2025: Strategies, Trends & Forecasts by Instrument Type, Application with Multiplex and Point of Care Market Analysis Globe Newswire ... of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. The report profiles 44 companies, large and small ...
10/7/2021 Global Immunoassay Markets Report 2021-2025: Strategies, Trends & Forecasts by Instrument Type, Application with Multiplex and Point of Care Market Analysis Yahoo News Dublin, Oct. 07, 2021 (GLOBE NEWSWIRE) -- The "Immunoassay Markets Strategies and Trends 2021 to 2025" report has been added to ResearchAndMarkets.com's offering.The workhorse of the diagnostic industry is finding new legs.The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay.Rapid diagnostics, point of care, biomarkers and consumer markets are all areas ...
10/7/2021 Global Immunoassay Markets Report 2021-2025: Strategies Globe Newswire Dublin, Oct. 07, 2021 (GLOBE NEWSWIRE) -- The "Immunoassay Markets Strategies and Trends 2021 to 2025" report has been added to ResearchAndMarkets.com's offering.The workhorse of the diagnostic industry is finding new legs.The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay.Rapid diagnostics, point of care, biomarkers and consumer markets are all areas ...
10/7/2021 Immunoassay Markets Strategies and Trends Report, Q4 2021 with Forecasts to 2025 - ResearchAndMarkets.com Business Wire ... of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. The report profiles 44 companies, large and small ...
9/29/2021 BELIEVE IN EVOLUTION? HELL, I’VE SEEN IT DONE: Plasmodium falciparum evolving to escape malaria ra… pjmedia.com September 29, 2021 BELIEVE IN EVOLUTION? HELL, I’VE SEEN IT DONE: Plasmodium falciparum evolving to escape malaria rapid diagnostics in Africa. A major tool against malaria in Africa has been the use of rapid diagnostic tests, which have been part of the “test-treat-track” strategy in Ethiopia, the second most-populated country in Africa. But researchers studying blood samples from more than 12,000 individuals in Ethiopia now ...
9/28/2021 Cue Health picks up $200M in IPO and more digital health fundings MobiHealthNews Photo: Kwanchai Lerttanapunyaporn/EyeEm/Getty ImagesRapid diagnostics startup Cue Health raised $200 million in its initial public offering Friday.As of market close on Monday, Cue was trading on Nasdaq for $18.63 under the ticker symbol “HLTH.” The company sought an offering of 12.5 million shares at $16 each. It was trading as high as $22.55 on Friday.Cue announced plans to go public in early September , months ...
9/28/2021 Plasmodium falciparum evolving to escape malaria rapid diagnostics in Africa Phys Org ... falciparum is evolving to escape malaria rapid diagnostic tests in Ethiopia, Nature Microbiology (2021). DOI: 10.1038/s41564-021-00962-4 Journal information: Provided by University of North Carolina Health Care Citation : Plasmodium falciparum evolving to escape malaria rapid diagnostics in Africa (2021, September 28) retrieved 28 September 2021 from https://phys.org/news/2021-09-plasmodium-falciparum-evolving-malaria-rapid.html This document is subject to copyright. Apart from any fair dealing for the purpose of ...
9/27/2021 Insights on the Point-of-Care/Rapid Diagnostics Global Market to 2027 - Featuring Abbott Laboratories, Danaher and Siemens Among Others - ResearchAndMarkets.com Yahoo News DUBLIN, September 27, 2021 --( BUSINESS WIRE )--The "Point-of-Care/Rapid Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.Amid the COVID-19 crisis, the global market for Point-of-Care/Rapid Diagnostics estimated at US$27.9 Billion in the year 2020, is projected to reach a revised size of US$49.6 Billion by 2027, growing at a CAGR of 8.6% over the analysis period 2020-2027 ...
9/27/2021 Insights on the Point-of-Care/Rapid Diagnostics Global Market to 2027 – Featuring Abbott Laboratories, Danaher and Siemens Among Others – ResearchAndMarkets.com digitalmedianet.com Insights on the Point-of-Care/Rapid Diagnostics Global Market to 2027 – Featuring Abbott Laboratories, Danaher and Siemens Among Others – ResearchAndMarkets.com Published Date: September 27, 2021DUBLIN–(BUSINESS WIRE)–The “Point-of-Care/Rapid Diagnostics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.Amid the COVID-19 crisis, the global market for Point-of-Care/Rapid Diagnostics estimated at US$27.9 ...
9/27/2021 Insights on the Point-of-Care/Rapid Diagnostics Global Market to 2027 – Featuring Abbott Laboratories, Danaher and Siemens Among Others – ResearchAndMarkets.com | Financial Buzz financialbuzz.com The “Point-of-Care/Rapid Diagnostics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.Amid the COVID-19 crisis, the global market for Point-of-Care/Rapid Diagnostics estimated at US$27.9 Billion in the year 2020, is projected to reach a revised size of US$49.6 Billion by 2027, growing at a CAGR of 8.6% over the analysis period 2020-2027.Glucose Monitoring Products ...
9/25/2021 Global Immunoassay Markets Strategies and Trends & Forecasts Report 2021-2023 – ResearchAndMarkets.com biotech-finances.com ... and Analysis. 2019 to 2023. » report has been added to ResearchAndMarkets.com’s offering. The workhorse of the diagnostic industry is finding new legs. Advances in genetic knowledge are creating new markets for immunoassay. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. We profile 44 companies, large and small, working ...
9/23/2021 T2 Biosystems Inc. [TTOO] moved up 3.34: Why It's Important dbtnews.com T2 Biosystems Inc. [NASDAQ: TTOO] gained 3.34% or 0.03 points to close at $0.98 with a heavy trading volume of 2081497 shares. The company report on September 14, 2021 that T2 Biosystems to Unveil New Data at September Conferences. Leading rapid diagnostics company to share new research at industry conferences throughout Sepsis Awareness Month. T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced ...
9/21/2021 FDA Clears First-of-its-Kind Test to Distinguish Between Bacterial and Viral Infections empr.com ... from a multicenter blinded clinical validation study (ClinicalTrials.gov Identifier: NCT04690569 ) that included over 1000 adults and children. “For those of us who care for acutely ill children, we have been waiting decades for accurate, rapid diagnostics to confidently guide the care of moderately ill children without a clear focus of infection or recognizable viral illness,” said Rich Bachur, MD, Professor of Pediatrics and Emergency Medicine, Harvard Medical School, and ...
9/16/2021 Prenetics, a Global Leader in Genomic and Diagnostic Testing, to Become Publicly Traded on the Nasdaq via Merger with Adrian Cheng's Artisan Acquisition Corp. Yahoo News Prenetics' mission is to disrupt and decentralise the healthcare industry with a global opportunity of over US$1.3 trillion .Prenetics' multi-product healthcare ecosystem strategy is driven by prevention focused genomic testing, rapid diagnostics for COVID-19 and infectious diseases, and colorectal cancer screening. To date, Prenetics has performed more than 5 million tests globally.Significant synergies with Adrian Cheng's network of millions of members spanning across retail, hospitality, healthcare ...
9/16/2021 Rapid Diagnostics Market Share, Growth, Statistics, by Application, Production, Revenue & Forecast to 2025 financialexpressnow.com Rapid Diagnostics Market Share, Growth, Statistics, by Application, Production, Revenue & Forecast to 2025 Rapid Diagnostics Market report provides (6 Forces Forecast 2019-2025) with in-depth analysis of Market Overview, Product Scope, Market Drivers, Trends, Opportunities, Market Driving Force and Market Risks. It also profile the topmost prime manufacturers (Roche Diagnostics, Alere, Siemens Healthcare, Abbott Diagnostics, Beckman Coulter, BD, Abaxis, Bayer HealthCare, Clarity Diagnostics, DiagCor Bioscience, Eiken Chemical, GlySens, OraSure Technologies ...
9/15/2021 Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2021 | Financial Buzz financialbuzz.com ... the US FDA to commence clinical trials in the United States. SACT-1 will be our second therapeutic program entering into the clinical phase. Our RPIDD program (liquid biopsy based approach to infectious disease rapid diagnostics ) is also progressing well and we are very pleased to continue its clinical validation currently in collaboration with A Star. Finally, we are excited to continue with our efforts of commercialising our NativusWell ® ...
9/14/2021 Cholera Vaccines Market Report 2018-2025 | Size, Share, Growth, Trends, Revenue Analysis, Competitive Landscape, Forecast | Grand View Research, Inc. manipurjournal.net ... to respond to an alert within 48 hours, household visits, and sensitization campaigns. Furthermore, various research projects and studies, such as epidemiological and anthropological studies, are being conducted in Africa. Ongoing studies include using rapid diagnostics tests to detect Vibrio cholerae in samples of water to understand epidemic diffusion mechanisms and anticipate outbreaks. The Cholera Platform is working with the Global Task Force for Cholera Control (GTFCC) WASH working group ...
9/14/2021 T2 Biosystems to Unveil New Data at September Conferences Globe Newswire LEXINGTON, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced it will unveil new data at industry conferences this month to showcase results and implications of the use of its rapid diagnostics technologies."We are committed to developing a library of clinical research to support and highlight the value of culture-independent rapid diagnostics for use ...
9/14/2021 Cholera Vaccines Market Report 2018-2025 | Size, Share, Growth, Trends, Revenue Analysis, Competitive Landscape, Forecast | Grand View Research, Inc. mysorenewspaper.com ... to respond to an alert within 48 hours, household visits, and sensitization campaigns. Furthermore, various research projects and studies, such as epidemiological and anthropological studies, are being conducted in Africa. Ongoing studies include using rapid diagnostics tests to detect Vibrio cholerae in samples of water to understand epidemic diffusion mechanisms and anticipate outbreaks. The Cholera Platform is working with the Global Task Force for Cholera Control (GTFCC) WASH working group ...